eFFECTOR Therapeutics Inc... (EFTR)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

eFFECTOR Therapeutics Statistics

Share Statistics

eFFECTOR Therapeutics has 4.70M shares outstanding. The number of shares has increased by -92.72% in one year.

Shares Outstanding 4.70M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 4.23M
Failed to Deliver (FTD) Shares 18
FTD / Avg. Volume 0.07%

Short Selling Information

The latest short interest is 91.62K, so 1.95% of the outstanding shares have been sold short.

Short Interest 91.62K
Short % of Shares Out 1.95%
Short % of Float 2.17%
Short Ratio (days to cover) 0.97

Valuation Ratios

The PE ratio is -0.71 and the forward PE ratio is null.

PE Ratio -0.71
Forward PE null
PS Ratio 0
Forward PS 0
PB Ratio -4.41
P/FCF Ratio -0.86
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

eFFECTOR Therapeutics Inc. has an Enterprise Value (EV) of -.

EV / Earnings null
EV / Sales null
EV / EBITDA null
EV / EBIT null
EV / FCF null

Financial Position

The company has a current ratio of 0.77, with a Debt / Equity ratio of -3.53.

Current Ratio 0.77
Quick Ratio 0.77
Debt / Equity -3.53
Total Debt / Capitalization 139.45
Cash Flow / Debt -1.44
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is 6.18% and return on capital (ROIC) is -229.45%.

Return on Equity (ROE) 6.18%
Return on Assets (ROA) -1.74%
Return on Capital (ROIC) -229.45%
Revenue Per Employee 0
Profits Per Employee -2.56M
Employee Count 14
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.8, so eFFECTOR Therapeutics 's price volatility has been higher than the market average.

Beta 0.8
52-Week Price Change null%
50-Day Moving Average 0.01
200-Day Moving Average 2.09
Relative Strength Index (RSI) 30.34
Average Volume (20 Days) 24.40K

Income Statement

In the last 12 months, eFFECTOR Therapeutics had revenue of $0 and earned -$35.81M in profits. Earnings per share was $-16.37.

Revenue 0
Gross Profit -22.92M
Operating Income -33.84M
Net Income -35.81M
EBITDA -33.73M
EBIT -
Earnings Per Share (EPS) -16.37
Full Income Statement

Balance Sheet

The company has $14.88M in cash and $20.55M in debt, giving a net cash position of -$5.67M.

Cash & Cash Equivalents 14.88M
Total Debt 20.55M
Net Cash -5.67M
Retained Earnings -179.38M
Total Assets 27.13M
Working Capital 681.00K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.55M and capital expenditures -$97.00K, giving a free cash flow of -$29.65M.

Operating Cash Flow -29.55M
Capital Expenditures -97.00K
Free Cash Flow -29.65M
FCF Per Share -13.56
Full Cash Flow Statement

Margins

Gross margin is 0%, with operating and profit margins of 0% and 0%.

Gross Margin 0%
Operating Margin 0%
Pretax Margin 0%
Profit Margin 0%
EBITDA Margin n/a%
EBIT Margin n/a%
FCF Margin n/a%

Dividends & Yields

EFTR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield -3150584.48%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for EFTR.

Price Target $24
Price Target Difference n/a
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jan 12, 2024. It was a backward split with a ratio of 1:25.

Last Split Date Jan 12, 2024
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -13.63
Piotroski F-Score 2